NCT02772731

Brief Summary

Breast cancer is the most common malignancy affecting women in the US. Surgical management is the mainstay of therapy, and in general consists of resection of the primary tumor with either a partial mastectomy (aka "lumpectomy") or a total mastectomy. The investigators hypothesize that routine shave margins during partial mastectomy will significantly reduce positive margin rate. A positive margin means that cancerous cells were detected at the edge of the excised area. This generally mandates a return to the operating room for re-excision.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
Completed

Started Jul 2016

Longer than P75 for not_applicable breast-cancer

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 9, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 13, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
6.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

January 31, 2025

Status Verified

January 1, 2025

Enrollment Period

1.9 years

First QC Date

May 9, 2016

Last Update Submit

January 30, 2025

Conditions

Keywords

mastectomy

Outcome Measures

Primary Outcomes (1)

  • Positive margin rate

    The effect is positive margin rate post-surgery as measured by local pathological reports. Positive margins were defined as tumor touching the edge of the specimen that was removed in patients with invasive cancer and tumor that was within 2 mm of the edge of the specimen removed in those with ductal carcinoma in situ.

    immediately after surgery

Secondary Outcomes (6)

  • local recurrence rates

    up to 5 years

  • patient perceived cosmesis

    1 year post-op

  • patient perceived cosmesis

    5 years post-op

  • volume of tissue resected

    immediately after tissue resection

  • Quality of Life assessment

    1 year post-op about the last seven days

  • +1 more secondary outcomes

Study Arms (2)

Shave Margin

EXPERIMENTAL

After partial mastectomy, patients will be subject to intraoperative randomization to the shave margin group where additional tissue will be resected.

Procedure: Partial mastectomy plus additional Shave Margin

No Shave Margin

ACTIVE COMPARATOR

After partial mastectomy, patients will be subject to intraoperative randomization to the no shave margin group, where after initial surgery, no further tissue will be removed.

Procedure: Partial mastectomy

Interventions

For the shave group, additional superior, inferior, medial and lateral margins will be removed, oriented, and sent for pathologic evaluation at the local site. Resection of additional anterior and posterior margins will be left to surgeon discretion, as this will depend on if skin or fascia was taken. All surgeons participating in the study will be educated on the expectation of what is considered a "shave margin". A shave margin is defined as an additional segment of breast tissue taken from each of the superior, inferior, medial, and lateral aspects of the cavity, such that the entire circumference of the cavity is re-excised following this procedure. Orientation of each shaved margin will be done to mark the true margin.

Shave Margin

Surgeons will be instructed to close after partial mastectomy with no further excision.

No Shave Margin

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Breast cancer, stage 0-3, deemed a surgically appropriate candidate for partial mastectomy with planned procedure for the same
  • Women ≥ 18 years of age
  • Ability to understand and the willingness to sign a written informed consent document.
  • Exlusion Criteria
  • Total mastectomy
  • Known metastatic disease
  • Bilateral synchronous breast cancer
  • Multicentric cancers requiring double lumpectomy
  • Previous history of breast cancer (even in the other breast)
  • Patients receiving Intraoperative radiation therapy (IORT)
  • Patients who had excisional biopsy for diagnosis of their cancer (I.e., instead of a core biopsy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Loma Linda University Cancer Center

Loma Linda, California, 92354, United States

Location

Watson Clinic Cancer and Research Center

Lakeland, Florida, 33805, United States

Location

William Beaumont Hospital

Troy, Michigan, 48085, United States

Location

UNC Chapel Hill

Chapel Hill, North Carolina, 27599-7213, United States

Location

Wake Forest School of Medicine

Winston-Salem, North Carolina, 27157, United States

Location

Cleveland Clinic Akron General

Akron, Ohio, 44307, United States

Location

Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

Location

Women & Infants Hospital

Providence, Rhode Island, 02905, United States

Location

Doctors Hospital at Renaissance

Edinburg, Texas, 78539, United States

Location

Related Publications (1)

  • Chagpar AB, Killelea BK, Tsangaris TN, Butler M, Stavris K, Li F, Yao X, Bossuyt V, Harigopal M, Lannin DR, Pusztai L, Horowitz NR. A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer. N Engl J Med. 2015 Aug 6;373(6):503-10. doi: 10.1056/NEJMoa1504473. Epub 2015 May 30.

    PMID: 26028131BACKGROUND

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Mastectomy, Segmental

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

MastectomySurgical Procedures, Operative

Study Officials

  • Anees Chagpar, MD

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2016

First Posted

May 13, 2016

Study Start

July 1, 2016

Primary Completion

June 1, 2018

Study Completion

November 1, 2024

Last Updated

January 31, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations